Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014
BOULDER, Colo., Oct. 29, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, November 4, 2014. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.
| Date: |
Tuesday, November 4, 2014 |
| Time: |
9:00 a.m. Eastern Time |
| Toll-Free: |
(800) 708-4540 |
| Toll: |
(847) 619-6397 |
| Pass Code: |
38177000 |
| Webcast, including Replay and Conference Call Slides: |
|
| http://www.media-server.com/m/acs/835a9ca60ab7df8747dc3aa3ad1d878b |
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 studies are in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.
| CONTACT: |
Tricia Haugeto |
| Array BioPharma Inc. |
|
| (303) 386-1193 |
|
SOURCE Array BioPharma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article